Dr Sonia Soopen explores the role of combination treatments using hyaluronic acid fillers, neuromodulators and polynucleotides
Botulinum toxin and hyaluronic acid (HA) dermal fillers have become the most popular choices for addressing the visible effects of facial ageing.1-3 Combining these modalities has become a standard of care when it comes to achieving the most harmonious and natural-looking facial rejuvenation results and addressing multiple concerns.3 More recently, polynucleotides have emerged as an injectable regenerative treatment to enhance skin quality.4,5
Combination treatments
Combination treatments can provide more desirable results.6,7 Emerging research also hints at the possibility that the synergy between dermal fillers and botulinum toxin may extend the longevity of results. The interplay between these treatments could potentially contribute to sustained effects over an extended period.6,7
The popularity of injectable agents, such as soft tissue fillers and botulinum toxin type A, has experienced a significant surge in recent years.8,9 This is attributed to the growing preference for…
